Literature DB >> 23708842

microRNA expression profiles in oral squamous cell carcinoma.

Daisuke Soga1, Sayaka Yoshiba, Sunao Shiogama, Hiroaki Miyazaki, Seiji Kondo, Satoru Shintani.   

Abstract

microRNAs (miRNAs) are involved in cancer pathogenesis, apoptosis and cell growth, thereby functioning as both tumor suppressors and oncogenes. However, the expression patterns and roles of miRNAs in oral squamous cell carcinoma (OSCC) remain largely unknown. We hypothesized that oral cancer may have a unique miRNA profile, which in turn may play a critical role in oral cancer development, progression, diagnosis and prognosis. We, therefore, investigated the expression profiles of 29 OSCC tumors and 7 normal oral mucosal samples. The miRNA expression patterns in OSCC were examined by TaqMan-based microRNA assays. We were subsequently able to identify the candidates of cancer-related miRNAs through analysis of the miRNA expression profiles. In conclusion, OSCC tissues were shown to have a unique miRNA profile pattern when compared with that in normal tissues. The present study may provide useful information for further investigation of the functional roles of miRNAs in OSCC development, progression, diagnosis and prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23708842     DOI: 10.3892/or.2013.2488

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  13 in total

1.  Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.

Authors:  F Momen-Heravi; A J Trachtenberg; W P Kuo; Y S Cheng
Journal:  J Dent Res       Date:  2014-04-09       Impact factor: 6.116

2.  Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma.

Authors:  Zonggao Shi; Jeffrey J Johnson; Rong Jiang; Yueying Liu; M Sharon Stack
Journal:  Arch Oral Biol       Date:  2015-06-20       Impact factor: 2.633

3.  Changes of serum miR-223-3p in patients with oral cancer treated with TPF regimen and the prognosis.

Authors:  Chunru Li; Yao Feng; Weiran Shao
Journal:  Oncol Lett       Date:  2020-01-24       Impact factor: 2.967

4.  Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.

Authors:  Yan Yan; Xuan Wang; Morten T Venø; Vivi Bakholdt; Jens A Sørensen; Annelise Krogdahl; Zheng Sun; Shan Gao; Jørgen Kjems
Journal:  Oncotarget       Date:  2017-01-31

Review 5.  Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: A systematic review.

Authors:  T N Uma Maheswari; Archana Venugopal; Nivedhita Malli Sureshbabu; Prathiba Ramani
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2018 Apr-Jun

6.  MicroRNA-133 Targets Phosphodiesterase 1C in Drosophila and Human Oral Cancer Cells to Regulate Epithelial-Mesenchymal Transition.

Authors:  Ji Eun Jung; Joo Young Lee; Hae Ryoun Park; Ji Wan Kang; Yun Hak Kim; Ji Hye Lee
Journal:  J Cancer       Date:  2021-07-03       Impact factor: 4.207

7.  MicroRNAs MiR-218, MiR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma.

Authors:  Shih-Chi Peng; Chun-Ta Liao; Chien-Hua Peng; Ann-Joy Cheng; Shu-Jen Chen; Chung-Guei Huang; Wen-Ping Hsieh; Tzu-Chen Yen
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

8.  Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma.

Authors:  Hyein Ahn; Jeong Mi Yang; Hyojin Kim; Jin-Haeng Chung; Soon-Hyun Ahn; Woo-Jin Jeong; Jin Ho Paik
Journal:  Oncotarget       Date:  2017-08-03

9.  MicroRNA meta-signature of oral cancer: evidence from a meta-analysis.

Authors:  Katarina Zeljic; Ivan Jovanovic; Jasmina Jovanovic; Zvonko Magic; Aleksandra Stankovic; Gordana Supic
Journal:  Ups J Med Sci       Date:  2018-02-26       Impact factor: 2.384

Review 10.  Immunomodulatory aspects in the progression and treatment of oral malignancy.

Authors:  Nobuo Kondoh; Masako Mizuno-Kamiya; Naoki Umemura; Eiji Takayama; Harumi Kawaki; Kenji Mitsudo; Yasunori Muramatsu; Shinichiro Sumitomo
Journal:  Jpn Dent Sci Rev       Date:  2019-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.